Major depressive disorder
For eligible adults who have not achieved satisfactory improvement from prior antidepressant medication in the current episode.
Review the depression meta-analysis ↗
Free consultation→EXOMIND rTMS treatment · Calgary, Alberta
Clearer thinking may begin with a different conversation.
If depression—including postpartum depression—anxiety symptoms associated with depression, OCD, binge-eating concerns, menopause-related mood or cognitive symptoms, difficulty with focus or attention, poor concentration, or brain fog are affecting your work and daily life, you deserve more than being told to push through. Discover whether clinician-guided EXOMIND rTMS may belong in your personalized care plan.
Non-invasiveNo surgery or anesthesiaWalk in, walk outResume usual activitiesClinically screenedPersonalized recommendations
EXOMINDAdvanced rTMS treatment
01 · Understanding treatment
What is EXOMIND?
EXOMIND uses repetitive transcranial magnetic stimulation (rTMS) to deliver controlled magnetic pulses to targeted areas of the brain.
Repeated stimulation can modulate activity in cortical networks and is studied for its relationship to neuroplasticity—the brain's capacity to adapt its activity and connections. Treatment is non-invasive, requires no anesthesia, and is delivered while you remain awake.
EXOMIND is a Health Canada-licensed Class II medical device. Suitability, protocol and expected outcomes depend on individualized clinical assessment.
Ask whether EXOMIND may fit your needs→
02 · A different approach
You are not weak.
Your brain may be overloaded.
There are times when everything feels heavier than it should. You are still working, managing responsibilities, and showing up for others—but your mind feels exhausted.
- Sleep does not restore your energy
- Your mind does not properly switch off
- Focus takes more effort than it used to
- Motivation and emotional balance feel harder to access
Persistent symptoms are not always about willpower. A clinical conversation can help clarify what may be contributing and what options are available.
03 · Licensed indications in Canada
Established clinical applications.
The manufacturer's Canadian product information identifies the following licensed indications. Treatment remains subject to clinical screening, contraindications and individualized planning.
Anxiety symptoms with MDD
Licensed in Canada for reducing symptoms of comorbid anxiety in patients living with major depressive disorder.
Read research on comorbid anxiety ↗Obsessive-compulsive disorder
May be used as an adjunct within a comprehensive treatment plan for eligible adults with OCD.
Review the OCD meta-analysis ↗Binge-eating disorder
A Health Canada-licensed indication delivered following clinical screening and individualized treatment planning.
Read the randomized clinical trial ↗Linked studies concern rTMS research generally. Study populations, devices and protocols may differ from EXOMIND treatment.
04 · Cognitive and life-stage concerns
Your symptoms deserve to be taken seriously.
Brain fog, mood changes and cognitive difficulties can be difficult to explain, but their impact is real. They can affect how quickly you think, how long you can concentrate and how confidently you function at work or at home.
These symptoms can have many causes. Our role is not to promise a one-size-fits-all solution—it is to help you understand whether EXOMIND may be a clinically reasonable option worth exploring.
These links show related rTMS research—not proof that EXOMIND treats every concern. Postpartum care requires individualized assessment, while menopause-specific, cognitive and long-COVID applications remain emerging, off-label or investigational.
Talk with us about your symptoms→Postpartum depression
When depression develops during pregnancy or after childbirth and deserves prompt, compassionate assessment and individualized treatment planning.
Read the peripartum depression systematic review ↗Menopause-related symptoms
When mood changes, brain fog or cognitive difficulties emerge during the menopause transition and warrant careful clinical and medical assessment.
View the menopause pilot-trial protocol ↗Focus & attention
When staying engaged, filtering distractions or returning to a task takes more effort than it should.
Review the ADHD research ↗Concentration
When meetings, reading or complex work become mentally exhausting and difficult to sustain.
Read the sustained-attention findings ↗Brain fog
When thinking feels slowed, words are harder to retrieve or your mind no longer feels reliably clear.
Read the long-COVID case series ↗Executive functioning
When planning, prioritizing, shifting between tasks or making decisions begins to feel overwhelming.
Review cognitive-effects research ↗Long-COVID symptoms
When persistent cognitive fatigue or brain fog continues after COVID-19 and deserves a careful clinical review.
View the ongoing pilot trial ↗Cognitive overload
When high demands, chronic stress or mental fatigue are affecting clarity, performance and recovery.
Explore the neuroplasticity review ↗05 · Emerging and off-label care
A reason to reach out—not a reason to give up.
If you are struggling with focus, attention, concentration, cognitive fatigue or long-COVID brain fog, a consultation can help you understand the available evidence and whether further assessment is appropriate.
Early research has explored rTMS for post-COVID brain fog and affective symptoms, and pilot clinical trials are continuing to study fatigue and cognitive symptoms. This area remains emerging. EXOMIND is not Health Canada-licensed specifically for long COVID, brain fog, ADHD or cognitive enhancement, and results cannot be guaranteed.
Off-label does not mean “without evidence” or “without clinical reasoning.” It means the decision must be individualized, transparent and made with informed consent after considering possible causes, medical coordination, potential benefits, limitations, risks and alternatives.
Request a confidential eligibility conversation→06 · Personalized care
Before treatment, we take time to understand your brain.
Clinical assessment helps us move beyond a one-size-fits-all approach. Your concerns, history, functioning, possible medical contributors and treatment goals guide the recommendations made for you.
UnderstandClarify symptoms and how they affect your life.
PersonalizeDetermine whether treatment is indicated and develop an appropriate plan.
MonitorReview comfort, functioning and progress throughout care.
07 · Your treatment journey
Clear, supported, and personalized.
Free consultation
Tell us what has changed—focus, clarity, energy, mood or daily functioning—and learn whether full screening is appropriate.
Clinical screening
Review medical history, symptoms, contraindications, possible contributors, goals and evidence-based alternatives.
Personalized sessions
If appropriate, receive clinician-guided rTMS treatment using a protocol selected for your care plan.
Progress review
Your response, comfort and functional goals are monitored throughout treatment.
Calgary treatment guides
Explore the concern most relevant to you.
Each guide explains what is established, what remains emerging and what a clinical consultation can clarify.
08 · Watch and learn
See EXOMIND in action.
Learn how the technology works and hear personal perspectives on the treatment experience. Individual experiences do not predict your outcome.
How EXOMIND works
Mechanism of action
Patient experiences
Personal perspectives
09 · Frequently asked questions
Questions are the right place to begin.
We want you to understand what is established, what is emerging and what requires an individualized clinical decision.
Ask us your question→Is rTMS being studied for postpartum depression?+
Yes. A systematic review and meta-analysis has examined rTMS for peripartum depression and found promising results, while also emphasizing the need for further research. Postpartum depression requires timely clinical assessment, including review of symptom severity, safety, medical history, breastfeeding considerations and available evidence-based treatments. EXOMIND suitability must be determined individually.
Can EXOMIND help with menopause-related brain fog or mood symptoms?+
Research specifically examining non-invasive brain stimulation during the menopause transition is at an early stage. A randomized pilot trial has been designed to study cognitive, mood and neurophysiological effects, but a study protocol does not establish treatment effectiveness. Menopause-related symptoms can have several causes and may require medical, hormonal, psychological or sleep assessment. EXOMIND is not specifically licensed for menopause symptoms.
Can EXOMIND help with focus, attention or concentration?+
These concerns can arise from depression, anxiety, sleep disruption, ADHD, post-viral illness and other medical or psychological factors. rTMS influences brain networks involved in cognition, but EXOMIND is not specifically licensed in Canada as a treatment for attention or concentration problems. A consultation helps determine what may be contributing and whether rTMS is a reasonable off-label consideration within a broader plan.
Can EXOMIND be considered for brain fog or long COVID?+
Research into rTMS for long-COVID brain fog and fatigue is emerging. Early studies and ongoing clinical trials make this a meaningful area to discuss, but it remains investigational and off-label. We begin with clinical screening and may recommend medical coordination or other assessment before treatment.
How is EXOMIND connected to neuroplasticity?+
Repeated magnetic stimulation can modulate activity in targeted cortical networks. Research on rTMS describes effects associated with neuroplasticity—the brain's capacity to adapt its activity and connections. This provides a scientific rationale for treatment, but it does not guarantee a particular cognitive or clinical result.
What does off-label treatment mean?+
Off-label means a clinician is considering a treatment for a symptom or condition outside the device's specifically licensed indication. It is not the same as an approved use. The decision requires individualized assessment, informed consent and a discussion of the evidence, uncertainties, risks and alternatives.
What is EXOMIND licensed to treat in Canada?+
The manufacturer's Canadian product information identifies major depressive disorder, reduction of comorbid anxiety symptoms in MDD, adjunctive treatment of adult OCD and binge-eating disorder. Eligibility and the appropriate protocol must still be determined clinically.
Will I need to stop medication?+
Do not stop medication without speaking with the prescribing clinician. EXOMIND may be considered alongside other forms of care, depending on your history, current treatment and clinical needs.
What does a session feel like?+
You remain awake while the applicator delivers magnetic pulses. Many people describe tapping or tingling at the treatment area. Temporary scalp discomfort or headache can occur, and risks and contraindications are reviewed before treatment.
How do I find out whether I may be a candidate?+
Book a confidential 15-minute consultation. We will listen to your concerns, explain the difference between licensed and off-label care, and identify whether a full clinical screening is the appropriate next step.
Clinical leadership
Meet Dr. Courtney Dookie
Registered Psychologist · Clinical Neuropsychology
Dr. Courtney Dookie brings a clinical psychology and neuropsychology perspective to understanding how mood, attention, memory, executive functioning and brain health affect daily life.
At Calgary Mind & Wellness Clinic, his approach emphasizes careful assessment, individualized treatment planning and clear communication about established, emerging and off-label care. The goal is to help each person understand what may be contributing to their symptoms and whether EXOMIND belongs within a responsible, evidence-informed care plan.
Speak with our clinic→
10 · Why choose us
Professional care. Personal attention.
Clinical leadership: Dr. Courtney Dookie
Registered Psychologist · Clinical Neuropsychology
Care informed by psychology, neuropsychology, assessment and brain-based treatment.
We distinguish licensed indications, emerging evidence and off-label considerations clearly.
Your recommendations are shaped by your history, concerns, functioning and goals.
EXOMIND may be considered within a broader medical and mental-health treatment plan.
Clinical screening matters
Is EXOMIND right for you?
Not everyone is eligible for rTMS. Tell your clinician about implanted metal or electronic devices, seizure or neurological history, pregnancy, medications, and recent health changes.
Temporary scalp discomfort or headache may occur. Benefits cannot be guaranteed, and your clinician will discuss expected benefits, limitations, alternatives, and risks for your situation.
Start with clarity.